Biblio
Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation. Pediatr Blood Cancer. 2023:e30577.
. Mixed donor chimerism following stem cell transplantation for sickle cell disease. Curr Opin Hematol. 2023.
. Organ function indications and potential improvements following curative therapy for sickle cell disease. Hematology Am Soc Hematol Educ Program. 2022;2022(1):277-282.
. Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood Adv. 2021.
A Comparison of Hematopoietic Cell Transplant Conditioning Regimens for Hemophagocytic Lymphohistiocytosis Disorders. J Allergy Clin Immunol. 2021.
.
Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial. JAMA Pediatr. 2019.
. Hematopoietic Stem Cell Transplantation: A Neonatal Perspective. Neoreviews. 2019;20(6):e336-e345.
. The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe). Biol Blood Marrow Transplant. 2018.
Higher risks of toxicity and incomplete recovery in 13-17 year old females after marrow donation: RDSafe peds results. Biol Blood Marrow Transplant. 2018.
Long-term Follow-up after Reduced Intensity Conditioning and Stem Cell Transplantation for Childhood Non-Malignant Disorders. Biol Blood Marrow Transplant. 2016.
Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions. Ther Adv Hematol. 2013;4(5):335-344.
.